{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:58:12Z","timestamp":1792807092284,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001826","name":"The Netherlands Organization for Health Research and Development","doi-asserted-by":"publisher","award":["836011024"],"award-info":[{"award-number":["836011024"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cmi.2019.09.019","type":"journal-article","created":{"date-parts":[[2019,10,13]],"date-time":"2019-10-13T10:01:31Z","timestamp":1570960891000},"page":"606-612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Antibiotic treatment for 6\u00a0days versus 12\u00a0days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial"],"prefix":"10.1016","volume":"26","author":[{"given":"D.R.","family":"Cranendonk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.C.","family":"Opmeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"van Agtmael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Branger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.I.M.","family":"Hoepelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.N.","family":"Lauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Oosterheert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.H.","family":"Pijlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.U.C.","family":"Sankatsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Soetekouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Veenstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.M.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.J.","family":"Wiersinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.09.019_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1001\/jama.2016.8825","article-title":"Cellulitis: a review","volume":"316","author":"Raff","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.09.019_bib2","first-page":"366","article-title":"Cellulitis: current insights into pathophysiology and clinical management","volume":"75","author":"Cranendonk","year":"2017","journal-title":"Neth J Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib3","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/bmj.332.7554.1355","article-title":"Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study","volume":"332","author":"el Moussaoui","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.cmi.2019.09.019_bib4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1001\/jamainternmed.2016.3633","article-title":"Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial","volume":"176","author":"Uranga","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0140-6736(12)60608-4","article-title":"Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial","volume":"380","author":"Sandberg","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.09.019_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(14)61233-2","article-title":"Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial","volume":"385","author":"Bernard","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.09.019_bib7","series-title":"Guidelines on the management of cellulitis in adults","author":"Clinical Resource Efficiency Support Team (CREST)","year":"2005"},{"key":"10.1016\/j.cmi.2019.09.019_bib8","series-title":"Richtlijn cellulitis en erysipelas van de onderste extremiteiten. Nederlandse Vereniging voor Dermatologie en Venereologie","author":"Lavrijsen APM","year":"2013"},{"key":"10.1016\/j.cmi.2019.09.019_bib9","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/archinte.164.15.1669","article-title":"Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis","volume":"164","author":"Hepburn","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib10","doi-asserted-by":"crossref","first-page":"ofv181","DOI":"10.1093\/ofid\/ofv181","article-title":"Etiology of cellulitis and clinical prediction of streptococcal disease: a prospective study","volume":"3","author":"Bruun","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib11","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1093\/clind\/15.Supplement_1.S148","article-title":"Evaluation of new anti-infective drugs for the treatment of selected infections of the skin and skin structure","volume":"15","author":"Calandra","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1471-2334-14-235","article-title":"Comparing short to standard duration of antibiotic therapy for patients hospitalized with cellulitis (DANCE): study protocol for a randomized controlled trial","volume":"14","author":"Cranendonk","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib14","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1310480","article-title":"Once-weekly dalbavancin versus daily conventional therapy for skin infection","volume":"370","author":"Boucher","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib15","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S1473-3099(14)70737-6","article-title":"Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial","volume":"14","author":"Moran","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib16","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1056\/NEJMoa1310422","article-title":"Single-dose oritavancin in the treatment of acute bacterial skin infections","volume":"370","author":"Corey","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib17","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1056\/NEJMoa1411162","article-title":"Trial of short-course antimicrobial therapy for intraabdominal infection","volume":"372","author":"Sawyer","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041290","article-title":"Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment","volume":"7","author":"Capellier","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.09.019_bib19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1086\/656431","article-title":"Skin and soft-tissue infections requiring hospitalization at an academic medical center: opportunities for antimicrobial stewardship","volume":"51","author":"Jenkins","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib20","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1001\/archinternmed.2011.29","article-title":"Decreased antibiotic utilization after implementation of a guideline for inpatient cellulitis and cutaneous abscess","volume":"171","author":"Jenkins","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib21","first-page":"486","article-title":"Clinical outcomes in patients hospitalized with cellulitis treated with oral clindamycin and trimethoprim\/sulfamethoxazole: the role of weight-based dosing","volume":"75","author":"Cox","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2019.09.019_bib22","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1001\/jama.2017.5653","article-title":"Effect of cephalexin plus trimethoprim-sulfamethoxazole vs cephalexin alone on clinical cure of uncomplicated cellulitis: a randomized clinical trial","volume":"317","author":"Moran","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.cmi.2019.09.019_bib23","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1206300","article-title":"Penicillin to prevent recurrent leg cellulitis","volume":"368","author":"Thomas","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1001\/archinte.167.7.709","article-title":"A predictive model of recurrent lower extremity cellulitis in a population-based cohort","volume":"167","author":"McNamara","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cmi.2019.09.019_bib25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/jamadermatol.2017.6196","article-title":"Effect of dermatology consultation on outcomes for patients with presumed cellulitis: a randomized clinical trial","volume":"154","author":"Ko","year":"2018","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.cmi.2019.09.019_bib26","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/bjd.16235","article-title":"Which outcomes are reported in cellulitis trials? Results of a review of outcomes included in cellulitis trials and a patient priority setting survey","volume":"178","author":"Smith","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cmi.2019.09.019_bib27","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1086\/340056","article-title":"Once-daily intravenous cefazolin plus oral probenecid is equivalent to once-daily intravenous ceftriaxone plus oral placebo for the treatment of moderate-to-severe cellulitis in adults","volume":"34","author":"Grayson","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib28","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/cid\/cit122","article-title":"Clinical trial: comparative effectiveness of cephalexin plus trimethoprim\u2013sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial","volume":"56","author":"Pallin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.09.019_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162947","article-title":"Toward an objective diagnostic test for bacterial cellulitis","volume":"11","author":"Pallin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.09.019_bib30","doi-asserted-by":"crossref","first-page":"ofy029","DOI":"10.1093\/ofid\/ofy029","article-title":"Time course of C-reactive protein and procalcitonin levels during the treatment of acute bacterial skin infections","volume":"5","author":"Jenkins","year":"2018","journal-title":"Open Forum Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930504X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X1930504X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:24:50Z","timestamp":1761117890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X1930504X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1198743X1930504X"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.09.019","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic treatment for 6\u00a0days versus 12\u00a0days in patients with severe cellulitis: a multicentre randomized, double-blind, placebo-controlled, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}